- HMRC has paused the imposition of VAT on free post-trial drugs following backlash from pharmaceutical companies.
- Drug firms warned that VAT on free medicines discourages clinical research and early access programs in the UK.
- Bayer suspended new patient enrollments for critical unmet needs due to the VAT issue, with other companies considering similar actions.
- The government is reviewing the policy after industry complaints, aiming to protect the UK’s reputation in life sciences research.
- The pause is intended to safeguard access to unlicensed treatments for patients with severe, untreatable illnesses before full NHS approval.
Source: pharmacy.biz
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
Latest Posts in "United Kingdom"
- Isle of Man Introduces VAT Relief for Business Donations to Registered Charities
- New Rules for Customs Duty Repayment Schemes in Northern Ireland Effective May 2026
- FTT Lacks Jurisdiction Over Appeal for Input VAT Incorrectly Charged by Supplier: Dowey v HMRC
- FTT Awards Costs to Appellant After HMRC’s Late Withdrawal in VAT Appeal: Kwok v HMRC
- FTT Upholds Director’s Liability for Input VAT Denial Under Kittel Principle in Butt v HMRC
